Catalyst Pharmaceuticals Inc., of Coral Gables, Fla., said it has started an underwritten public offering of 8 million shares of its common stock, and underwriters have been granted a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering on the same terms and conditions.